Effect of N-Acetylcysteine on cystatin C-Based renaL function after Elective coronary angiography (ENABLE Study): A prospective, randomized trial

International Journal of Cardiology

Volumn 138, Issue 3, 2010, Pages 239-245

  Kim, Byung Jin ^a   Sung, Ki Chul ^a   Kim, Bum Soo ^a   Kang, Jin Ho ^a   Lee, Kyu Beck ^a   Kim, Hyang ^a   Lee, Man Ho ^a  

^a School of Medicine   (South Korea)

Author keywords

Acetylcysteine; Cystatin C; Renal insufficiency

Indexed keywords

ACETYLCYSTEINE; CREATININE; CYSTATIN C; IOBITRIDOL; IODIXANOL; IOPAMIDOL; NITROGEN; RADISENSE; UNCLASSIFIED DRUG; UREA;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; UREA NITROGEN BLOOD LEVEL;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; CYSTATIN C; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 74449090214     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.08.013     Document Type: Article

References (40)

1. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
2. McCullough P.A., Wolyn R., Rocher L.L., et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
3. Gupta R., Gurm H.S., Bhatt D.L., et al. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64 (2005) 442-448
4. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 4 (2004) 1393-1399
5. Bakris G.L., Lass N., Gaber A.O., et al. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol Renal Physiol 258 (1990) 115-120
6. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
7. Heyman S.N., Clark B.A., Kaiser N., et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3 (1992) 58-65
8. Pannu N., Wiebe N., and Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
9. Shemesh O., Golbetz H., Kriss J.P., et al. Limitations of creatinine as filtration marker in glomerulopathic patients. Kidney Int 28 (1985) 830-836
10. Perrone R.D., Madis N.E., and Levey A.S. Serum creatinine as a index of renal function: new insights into old concepts. Clin Chem 38 (1992) 1933-1953
11. Laterza O.F., Price C.P., and Scott M.G. An improved estimator of glomerular filtration rate?. Clin Chem 48 (2002) 699-707
12. Filler G., Bökenkamp A., Hofmann W., et al. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38 (2005) 1-8
13. Kyhse-Andersen J., Schmidt C., Nordin G., et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40 (1994) 1921-1926
14. Dharnidharka V., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40 (2002) 221-226
15. Rickli H., Benou K., Ammann P., et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 61 (2004) 98-102
16. Gleeson T.G., and Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 183 (2004) 1673-1689
17. Bellomo R., Kellum J.A., and Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 30 (2004) 33-37
18. Pucci L., Triscornia S., Lucchesi D., et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 53 (2007) 480-488
19. Herget-Rosenthal S., Marggraf G., Hüsing J., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 66 (2004) 1115-1122
20. Coll E., Botey A., Alvarez L., et al. Seum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36 (2000) 29-34
21. Finney H., Newman D.J., and Price C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 37 (2000) 49-59
22. Bökenkamp A., Domanetzki M., Zinck R., et al. Cystatin C-A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101 (1998) 875-881
23. Finney H., Newman D.J., Gruber W., et al. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA, BN II). Clin Chem 43 (1997) 1016-1022
24. Mussap M., Dalla Vestra M., Fioretto P., et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61 (2002) 1453-1461
25. Brezis M., and Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332 (1995) 647-655
26. Brunet J., Boily M.J., Cordeau S., et al. Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radic Biol Med 19 (1995) 627-638
27. Safirstein R., Andrade L., and Vieira J.M. Acetylcysteine and nephrotoxic effects of radiographic contrast agents-a new use for an old drug. N Engl J Med 343 (2000) 210-212
28. Kay J., Chow W.H., Chan T.M., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized control trial. JAMA 289 (2003) 553-558
29. Boccalandro F., Amhad M., Smalling R.W., et al. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv 58 (2003) 336-341
30. Shyu K.G., Cheng J.J., and Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40 (2002) 1383-1388
31. Birck R., Krzossok S., Markowetz F., et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
32. Nallamothu B.K., Shojania K.G., Saint S., et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 114 (2004) 938-947
33. Kshirsagar A.V., Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
34. Alonso A. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 45 (2004) 1-9
35. Carbonell N., Blasco M., Sanjuán R., et al. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomized trial. Int J Cardiol 115 (2007) 57-62
36. Poletti P.A., Saudan P., Platon A., et al. IV N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. Am J Roentgenol 189 (2007) 687-692
37. Toprak O. Risk markers for contrast-induced nephropathy. Am J Med Sci 334 (2007) 283-290
38. Briguori C., Colombo A., Airoldi F., et al. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int 68 (2005) 2250-2255
39. Sharma S.K., and Kini A. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv 65 (2005) 386-393
40. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150